DOI
10.1016/j.addbeh.2022.107329
The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials
作者地址
Lanzhou Univ, Hlth Technol Assessment Ctr, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, Lanzhou, Peoples R China
通讯作者
Yang, Kehu;Li, Xiuxia
来源期刊
Addict Behav
ISSN
0306-4603
EISSN
1873-6327
出版日期
2022-04-01
卷号
131
摘要
Objective: A network meta-analysis (NMA) was conducted to investigate the effect of varenicline (VAR), bupropion (BUP), and nicotine replacement therapy (NRT) on smoking cessation. Methods: Eight databases were searched in May 2021, and only randomized controlled trials (RCTs) using varenicline, bupropion, or NRT (single or combined) for smoking cessation were included. The risk of bias in the included RCTs was assessed using the Cochrane Handbook tool. Stata 15.1 software was used to perform NMA, and the quality of the evidence was evaluated using Confidence in Network Meta-analysis (CINeMA). Findings: Twenty RCTs involving 16,702 smokers were included. The risk of bias results showed that 10 RCTs were rated as high, three were low, and seven were unclear. A total of 21 pairs were compared based on seven interventions. The NMA showed that, compared to the placebo (PLA), the other six interventions had significant efficacy in smoking cessation, where VAR + BUP showed the best effect of all treatments (odds ratio (OR) = 6.08, 95% confidence interval (CI) [3.47, 10.66]). Moreover, VAR + BUP was superior to VAR + NRT (OR = 1.66, 95% CI [1.07, 2.59]) and the three monotherapies (VAR, BUP, and NRT). In the monotherapies, the results of pairwise comparisons of VAR, BUP, and NRT did not show significant differences. Finally, the surface under the cumulative ranking curve (SUCRA) value indicated that VAR + BUP had the greatest probability of becoming the best intervention. Conclusions: The efficacy of VAR, BUP, and NRT alone increased the odds of smoking abstinence better than the placebo, combined interventions were superior to monotherapy, and VAR combined with other interventions had a better smoking cessation effect.
资助信息
National Natural Science Foundation of China (Grant: 72074103);the Fundamental Research Funds for the Central Universities (lzujbky-2021-ct06, lzujbky-2021-kb22) ; the Gansu Special Project of Soft Science (20CX9ZA109)
资助机构
国家自然科学基金委员会 ; 中华人民共和国财政部 ; 中华人民共和国教育部 ; 甘肃省科技厅
语种
English
国家
学科领域
收录类别
SCIE ; SSCI
WOS学科分类
Psychology, ClinicalSubstance Abuse
WOS关键词
Author Keywords:Bupropion ; Varenicline ; Smoking cessation ; Network meta-analysis Keywords Plus:NICOTINE REPLACEMENT THERAPY ; RECEPTOR PARTIAL AGONIST ; SUSTAINED-RELEASE BUPROPION ; SYSTEMATIC REVIEWS ; CLINICAL-TRIAL ; QUIT SMOKING ; PATCH ; EFFICACY ; PLACEBO ; QUALITY
被引频次(WOS)
13
研究类型
Meta分析

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。